Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
American Journal of Hematology|July 1, 1988
Amsacrine is safe in patients with ventricular ectopyC A Puccio, E J Feldman, Z A ArlinLeukemia & Lymphoma|July 27, 2016
Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous LeukemiaE J Feldman, S Biguzzi, T Ahmed, et al.Acta Haematologica|January 1, 1989
Acute promyelocytic leukemia: a 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhageE J Feldman, Z A Arlin, T Ahmed, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemiaC A Puccio, A Mittelman, S M Lichtman, et al.Leukemia|January 1, 1996
Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemiaE J Feldman, K P Seiter, T Ahmed, et al.International Journal of Clinical & Laboratory Research|January 1, 1992
Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapyZ A Arlin, T Ahmed, A Mittelman, et al.Leukemia|October 1, 1987
Are two courses of chemotherapy required in phase II trials in acute leukemia?Z A ArlinActa Haematologica|January 1, 1989
Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) is resistant to effective therapy for Ph1-negative ALLZ A Arlin, E J Feldman, T Ahmed, et al.Leukemia & Lymphoma|April 17, 2010
Current status of mitoxantrone combination chemotherapy programs: a personal viewZ A ArlinLeukemia & Lymphoma|July 27, 2016
Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion ScheduleS M Lichtman, A Mittelman, D R Budman, et al.Pageof 9